This process occurs in the intestinal L cells of the gastrointestinal tract leading to the co-secretion of GLP-1 and oxyntomodulin in response to nutrient sensing ( Figure 1 Whilst much attention was focused on GLP-1 in the 1980s and 90s, following the discovery of its incretin effect in humans ( Concurrent to the pre-clinical studies, the first human study of oxyntomodulin was carried out in a small double-blind placebo-controlled crossover study ( ad-libitum food intake was significantly reduced in participants receiving OXM compared to saline control and a cumulative caloric intake reduction was observed up to 12 hours later
Subgroup analyses based on study duration, L-carnitine dose, sample size, age, and health status were conducted to identify potential sources of heterogeneity
[DOI] [PubMed] [Google Scholar] 105.Sczelecki S., Besse-Patin A., Abboud A., Kleiner S., Laznik-Bogoslavski D., Wrann C.D., Ruas J.L., Haibe-Kains B., Estall J.L
240 Then ferroptosis causes cells death and accelerates the development of T2DM
Health" loading="lazy"/>
